A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer

References

• FerlayJShinHRBrayFGLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer base No 10[EB/OL] Available from: http://globocan.iarc.fr, 2011-02-20
   Google Scholar
• ZouXNDuanJJHuangpuXMAn analysis of stomach cancer mortality in the national retrospective sampling survey of death causes in China, 2004–2005Chin J Prevent Med Sci2010445390397
   Google Scholar
• RoxburghCSMcMillanDCRole of system inflammatory response in predicting survival in patients with primary operable cancerFuture Oncol2010614916320021215
   PubMed Web of Science ®Google Scholar
• ArgilesJMBusquetsSToledoMLopez-SorianoFJThe role of cytokines in cancer cachexiaCurr Opin Support Palliat Care20093163168
   Google Scholar
• BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
   PubMed Web of Science ®Google Scholar
• CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
   PubMed Web of Science ®Google Scholar
• KusumantoYHDamWAHospersGAMeijerCMulderNHPlatelets and granulocytes, in particular the neutrophils, from important compartments for circulating vascular endothelial growth factorAngiogenesis20036428328715166496
   PubMedGoogle Scholar
• UlichTRDelCJGuoKIn vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCsBlood1989731081102783370
   PubMed Web of Science ®Google Scholar
• PhilipMRowleyDASchreiberHInflammation as a tumor promoter in cancer inductionSemin Cancer Biol20041443343915489136
   PubMed Web of Science ®Google Scholar
• HeikkilaKEbrahimSLawlorDAA systematic review of the association between circulating concentrations of C reactive protein and cancerJ Epidemiol Commun Health200761824833
   PubMed Web of Science ®Google Scholar
• ForrestLMMcMillanDCMcArdleCSComparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancerBr J Cancer2004901704170615150622
   PubMed Web of Science ®Google Scholar
• ForrestLMMcMillanDCMcArdleCSA prospective longitudinal study of performance status, an inflammation-based prognostic score (GPS) and survival in patients with inoperable non-small-cell lung cancerBr J Cancer2005921834183615870712
   PubMed Web of Science ®Google Scholar
• ProctorMJMorrisonDSTalwarDA comparison of inflammation-based prognostic score in patients with cancer. A Glasgow inflammation outcome studyEur J Cancer20112031101106
   Google Scholar
• SharmaRHookJKumarMGabraHEvaluation of an inflammation-based prognostic score in patients with advanced ovarian cancerEur J Cancer20084425125618155897
   PubMed Web of Science ®Google Scholar
• SharmaRZucknickMLondonRKacevskaMLiddleCClarkeSJSystemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancerClin Colorectal Cancer2008733133718794066
   PubMed Web of Science ®Google Scholar
• RamseySLambGWAitchisonMGrahamJMcMillanDCEvaluation of an inflammation-based prognostic score in patients with metastatic renal cancerCancer200710920521217149754
   PubMed Web of Science ®Google Scholar
• HuangJXuLLuoYHeFZhangYChenMThe inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomyMed Oncol201431488324535607
   PubMed Web of Science ®Google Scholar
• IshizukaMKubotaKKitaJImpact of an inflammation based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patientsAm J Surg2012203110110621429472
   PubMed Web of Science ®Google Scholar
• YingHQDengQWHeBSPanYQWangFSunHLThe prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patientsMed Oncol2014311230525355641
   PubMed Web of Science ®Google Scholar
• AzabBShahNRadbelJPretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patientsMed Oncol201330143223283648
   PubMed Web of Science ®Google Scholar
• SmithRABosonnetLRaratyMPreoperative platelet–lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinomaAm J Surg2009197446647218639229
   PubMed Web of Science ®Google Scholar
• HeWYinCGuoGInitial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancerMed Oncol201330143923307251
   PubMed Web of Science ®Google Scholar
• KasymjanovaGMacDonaldNAgulnikJSThe predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancerCurr Oncol2010174525820697515
   PubMed Web of Science ®Google Scholar
• ProctorMJMorrisonDSTalwarDA comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome studyEur J Cancer201147172633264121724383
   PubMed Web of Science ®Google Scholar
• PinatoDJNorthBVSharmaRA novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)Br J Cancer201210681439144522433965
   PubMed Web of Science ®Google Scholar
• IshizukaMKubotaKKitaJImpact of an inflammation based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patientsAm J Surg2012203110110621429472
   PubMed Web of Science ®Google Scholar
• KinoshitaAOnodaHImaiNComparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinomaBr J Cancer2012107698899322878374
   PubMed Web of Science ®Google Scholar
• SumantaDAndrewBGrantMComparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancerCancer World J Surg20013518611866
   Google Scholar
• HirashimaMHiguchiSSakamotoKThe ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancerJ Cancer Res Clin Oncol19981243293349692841
   PubMed Web of Science ®Google Scholar
• ShimadaHTakiguchiNKainumaOHigh preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancerGastric Cancer201013317017620820986
   PubMed Web of Science ®Google Scholar
• DuttaSCrumleyABFullartonGMHorganPGMcMillanDCComparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancerAm J Surg2012204329429922444831
   PubMed Web of Science ®Google Scholar
• DeshenWChaoRMiaoZQComparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancerTumor Biol2012333749756
   Google Scholar
• MarreroJAFontanaRJBarratAPrognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohortHepatology20054170771615795889
   PubMed Web of Science ®Google Scholar
• YamanakaTMatsumotoSTeramukaiSIshiwataRNagaiYFukushimaMThe base line ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancerOncology2007733–421522018424885
   PubMed Web of Science ®Google Scholar
• JungMRParkYKJeongOElevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancerJ Surg Oncol2011104550451021618251
   PubMed Web of Science ®Google Scholar
• LeeSOhSYKimSHPrognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer20131335023876227
   PubMed Web of Science ®Google Scholar
• GungorTKanat-PektasMSucakAMollamahmutogluLThe role of thrombocytosis in prognostic evaluation of epithelial ovarian tumorsArch Gynecol Obstet20092791535618470520
   PubMed Web of Science ®Google Scholar
• IkedaMFurukawaHImamuraHPoor prognosis associated with thrombocytosis in patients with gastric cancerAnn Surg Oncol20029328729111923136
   PubMed Web of Science ®Google Scholar
• CrumleyABMcMillanDCMcKernanMMcDonaldACStuartRCEvaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancerBr J Cancer20069463764116479253
   PubMed Web of Science ®Google Scholar
• SakuramaltoSSasakoMYamaguchiTAdjuvant chemotherapy for gastric cancer with s-1, an oral fluoropyrimidineN Engl J Med2007357181810182017978289
   PubMed Web of Science ®Google Scholar
• BangYJKimYWYangHKAdjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialLancet201237931532122226517
   PubMed Web of Science ®Google Scholar
• ClarkeSJChuaMMooreMUse of inflammatory markers to guide cancer treatmentClin Pharmacol Ther20119047547821775983
   PubMed Web of Science ®Google Scholar
• AggarwalBBVijayalekshmiRVSungBTargeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foeClin Cancer Res20091542544019147746
   PubMed Web of Science ®Google Scholar
• McMillanDCScorrHRWatsonWSLongitudinal study of body cell mass depletion and the inflammatory response in cancer patientsNutr Cancer1998311011059770720
   PubMed Web of Science ®Google Scholar
• AndreyevHNormanAROatesJCunninghamDWhy do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?Eur J Cancer1998345035099713300
   PubMed Web of Science ®Google Scholar
• StephensMRLewisWGWhiteSPrognostic significance of alarm symptoms in patients with gastric cancerBr J Surg200592784084615892157
   PubMed Web of Science ®Google Scholar
• CostaMLde Cassia Braga RibeiroKMachadoMACostaACMontagniniALPrognostic score in gastric cancer: the importance of a conjoint analysis of clinical pathologic and therapeutic factorsAnn Surg Oncol200613684385016614885
   PubMed Web of Science ®Google Scholar